Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Centene
(NYSE:CNC)
Intraday
$73.83
-0.17
[-0.23%]
After-Hours
$73.83
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$73.83
-0.17
[-0.23%]
At close: Apr 29
$73.83
0
[0.00%]
After Hours: 4:06PM EDT
Get Report
Watch
Q1 2024 Earnings were released on Fri Apr 26th, before the market open
The most recent conference call was at 8:30 AM, 4 days ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Centene Stock (NYSE:CNC)
Centene Stock (NYSE: CNC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 29, 2024
Oppenheimer Maintains Outperform on Centene, Maintains $110 Price Target
Benzinga Newsdesk
-
11 hours ago
Friday, April 26, 2024
Centene's First-Quarter Surge: Sales Soar To $40.41B, Exceeding Expectations: What's Next For The Healthcare Company?
Vandana Singh
-
3 days ago
Centene shares are trading higher after the company reported better-than-expected Q1 2024 adjusted EPS and sales. Additionally, the company raised upbeat its guidance for 2024.
Benzinga Newsdesk
-
3 days ago
Centene Expects 2024 Revenue Guidance Of $147.5B-$150.5B Versus Consensus Of $146.14B, Including Premium And Service Revenues Of $135.5B-$138.5B Versus Prior Guidance Of $134.5B-$137.5B
Benzinga Newsdesk
-
3 days ago
Centene Revises Its 2024 Adjusted EPS Guidance Floor Of Greater Than $6.80 Versus Prior Guidance Of Greater Than $6.70 Versus Consensus Of $6.78
Benzinga Newsdesk
-
3 days ago
Centene Reports Q1 Health Benefits Ratio Of 87.1%, With Membership Of 28,422,800
Benzinga Newsdesk
-
3 days ago
Centene Q1 2024 Adj EPS $2.26 Beats $2.08 Estimate, Sales $40.407B Beat $36.536B Estimate
Benzinga Newsdesk
-
3 days ago
Wednesday, April 24, 2024
Humana Tops Q1 Earnings and Revenue Estimates
Zacks
-
5 days ago
Monday, April 22, 2024
Looking Into Centene's Recent Short Interest
Benzinga Insights
-
Apr 22, 2024, 3:45PM
Tuesday, April 16, 2024
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
Piero Cingari
-
Apr 16, 2024, 1:28PM
Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
Shanthi Rexaline
-
Apr 16, 2024, 7:24AM
Monday, April 15, 2024
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
Vandana Singh
-
Apr 15, 2024, 2:17PM
Evaluating Centene: Insights From 7 Financial Analysts
Benzinga Insights
-
Apr 15, 2024, 2:01PM
Centene shares are trading higher after Florida announced Statewide Medicaid Managed Care Program awards, under which the company secured a statewide contract.
Benzinga Newsdesk
-
Apr 15, 2024, 9:12AM
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
-
Apr 15, 2024, 8:39AM
Wells Fargo Maintains Overweight on Centene, Raises Price Target to $93
Benzinga Newsdesk
-
Apr 15, 2024, 8:17AM
Thursday, April 11, 2024
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,700 Today
Benzinga Insights
-
Apr 11, 2024, 4:30PM
Monday, April 08, 2024
Wells Fargo Maintains Overweight on Centene, Lowers Price Target to $89
Benzinga Newsdesk
-
Apr 8, 2024, 8:32AM
Thursday, April 04, 2024
Cantor Fitzgerald Reiterates Overweight on Centene, Maintains $90 Price Target
Benzinga Newsdesk
-
Apr 4, 2024, 10:00AM
Tuesday, April 02, 2024
Benzinga Opening Bell Update: Tesla Falls On Delivery Numbers, Oil Gains On Middle East Tensions, Healthcare Providers Drop On Medicare Advantage Rates
Benzinga Newsdesk
-
Apr 2, 2024, 9:34AM
Shares of healthcare providers are trading lower after the CMS finalized payment updates for the 2025 Medicare Advantage and Medicare Part D programs.
Benzinga Newsdesk
-
Apr 2, 2024, 7:04AM
Monday, April 01, 2024
Shares of several healthcare providers are trading lower after the CMS finalized payment updates for the 2025 Medicare Advantage and Medicare Part D programs.
Benzinga Newsdesk
-
Apr 1, 2024, 4:35PM
CMS Says Under 2025 Rate Announcement, Payments From Gov. To MA Plans Are Expected To Increase On Average By 3.70%, From 2024; Federal Government Is Projected To Pay Between $500B-$600B In Medicare Advantage Payments To Private Health Plans In 2025
Benzinga Newsdesk
-
Apr 1, 2024, 4:29PM
CMS Finalizes Payment Updates For 2025 Medicare Advantage And Medicare Part D Programs
Benzinga Newsdesk
-
Apr 1, 2024, 4:27PM
Wednesday, March 27, 2024
$1000 Invested In Centene 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Mar 27, 2024, 2:30PM
Tuesday, March 26, 2024
Peering Into Centene's Recent Short Interest
Benzinga Insights
-
Mar 26, 2024, 12:00PM
HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
Benzinga Newsdesk
-
Mar 26, 2024, 8:54AM
Monday, March 25, 2024
Disney To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
-
Mar 25, 2024, 8:39AM
5 Analysts Have This To Say About Centene
Benzinga Insights
-
Mar 25, 2024, 8:00AM
Stephens & Co. Downgrades Centene to Equal-Weight, Lowers Price Target to $85
Benzinga Newsdesk
-
Mar 25, 2024, 7:29AM
Thursday, March 21, 2024
Stephens & Co. Downgrades Centene to Equal-Weight, Lowers Price Target to $85
Benzinga Newsdesk
-
Mar 21, 2024, 8:09AM
Wednesday, March 20, 2024
Wells Fargo Maintains Overweight on Centene, Raises Price Target to $94
Benzinga Newsdesk
-
Mar 20, 2024, 10:51AM
Thursday, March 14, 2024
Here's How Much You Would Have Made Owning Centene Stock In The Last 20 Years
Benzinga Insights
-
Mar 14, 2024, 2:00PM
Monday, March 11, 2024
Centene Expects To Reaffirm Its Previously Issued 2024 Adjusted EPS Guidance Of Greater Than $6.70; Est $6.78
Benzinga Newsdesk
-
Mar 11, 2024, 4:50PM
Wednesday, March 06, 2024
Assessing Centene: Insights From 6 Financial Analysts
Benzinga Insights
-
Mar 6, 2024, 7:00AM
Barclays Initiates Coverage On Centene with Overweight Rating, Announces Price Target of $101
Benzinga Newsdesk
-
Mar 6, 2024, 6:19AM
Monday, February 26, 2024
Here's How Much You Would Have Made Owning Centene Stock In The Last 10 Years
Benzinga Insights
-
Feb 26, 2024, 9:30AM
Friday, February 16, 2024
Major Decision: Jean Lori Robinson Exercises Options, Realizing $237K At Centene
Benzinga Insights
-
Feb 16, 2024, 10:01AM
Friday, February 09, 2024
Alphabet, Visa And 2 Other Stocks Insiders Are Selling
Avi Kapoor
-
Feb 9, 2024, 7:52AM
Wednesday, February 07, 2024
$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Feb 7, 2024, 1:30PM
Tuesday, February 06, 2024
Crude Oil Gains 1%; Centene Sales Top Views
Avi Kapoor
-
Feb 6, 2024, 12:08PM
Centene's Q4 Profits Reach $45M On Higher Membership, Premium As Enrollments Increase
Vandana Singh
-
Feb 6, 2024, 10:58AM
Centene shares are trading higher the company reported better-than-expected Q4 FY23 financial results and issued guidance.
Benzinga Newsdesk
-
Feb 6, 2024, 6:10AM
Centene Reiterates Its 2024 Adjusted EPS Guidance Floor Of Greater Than $6.70 Versus Consensus Of $6.75
Benzinga Newsdesk
-
Feb 6, 2024, 6:09AM
Centene Increases Its 2024 Premium And Service Revenues Guidance Range By $2.5B To $134.5B-$137.5B, To Reflect Additional Commercial Premium Revenue From A Stronger Than Expected Marketplace Open Enrollment
Benzinga Newsdesk
-
Feb 6, 2024, 6:08AM
Centene Q4 Adjusted EPS $0.45 Beats $0.43 Estimate, Sales $39.46B Beat $36.14B Estimate
Benzinga Newsdesk
-
Feb 6, 2024, 6:02AM
Earnings Scheduled For February 6, 2024
Benzinga Insights
-
Feb 6, 2024, 5:42AM
Monday, February 05, 2024
Earnings Preview For Centene
Benzinga Insights
-
Feb 5, 2024, 9:01AM
Thursday, February 01, 2024
(CNC) - Analyzing Centene's Short Interest
Benzinga Insights
-
Feb 1, 2024, 12:15PM
Thursday, January 25, 2024
Affordable Care Act Enrollment Highest Since Inception: Obamacare Enrollment Witnesses 31% Jump in 2024
Vandana Singh
-
Jan 25, 2024, 9:44AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch